| Reference |
|---|
xc7 apk x131 n E, Kutlu A, Y xfc ce M. Repurposing Fc gamma receptor I (FcγRI, CD64) for site-oriented monoclonal antibody capture: A proof-of-concept study for real-time detection of tumor necrosis factor-alpha (TNF -α). Heliyon. 2023;9:e19469 pubmed publisher |
Torchia J, Tavares A, Carstensen L, Chen D, Huang J, Xiao T, et al. Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo. Sci Adv. 2022;8:eabq6527 pubmed publisher |
An S, Yang B, Jang G, Kim D, Kim J, Oh S, et al. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy. Nat Commun. 2022;13:5669 pubmed publisher |
Rogel A, Ibrahim F, Thirdborough S, Renart Depontieu F, Birts C, Buchan S, et al. Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. JCI Insight. 2022;7: pubmed publisher |
Kitanaga Y, Yamajuku D, Kubo S, Nakamura K, Maeda M, Seki M, et al. Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus. Int Immunopharmacol. 2021;101:108343 pubmed publisher |
Wessel A, Doyle M, Engdahl T, Rodriguez J, Crowe J, Diamond M. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection. MBio. 2021;12:e0244021 pubmed publisher |
Aitken E, Damelang T, Ortega Pajares A, Alemu A, Hasang W, Dini S, et al. Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria. elife. 2021;10: pubmed publisher |
Vanhove B, Duvaux O, Rousse J, Royer P, Evanno G, Ciron C, et al. High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2. Eur J Immunol. 2021;51:1412-1422 pubmed publisher |
Zekri L, Vogt F, Osburg L, M xfc ller S, Kauer J, Manz T, et al. An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer. EMBO Mol Med. 2021;13:e11902 pubmed publisher |
Wessel A, Kose N, Bombardi R, Roy V, Chantima W, Mongkolsapaya J, et al. Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy. Nat Commun. 2020;11:5278 pubmed publisher |
An J, Li L, Lee J, Yu S, Kim J, Lee J, et al. Urinary cMet as a prognostic marker in immunoglobulin A nephropathy. J Cell Mol Med. 2020;24:11158-11169 pubmed publisher |
Blundell P, Lu D, Wilkinson M, Dell A, Haslam S, Pleass R. Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus. J Immunol. 2019;202:1595-1611 pubmed publisher |
Oshima T, Miyashita H, Ishimura Y, Ito Y, Tanaka Y, Hori A, et al. Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey. PLoS ONE. 2018;13:e0196422 pubmed publisher |
Arce Vargas F, Furness A, Litchfield K, Joshi K, Rosenthal R, Ghorani E, et al. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer Cell. 2018;33:649-663.e4 pubmed publisher |
Geuijen K, Oppers Tiemissen C, Egging D, Simons P, Boon L, Schasfoort R, et al. Rapid screening of IgG quality attributes - effects on Fc receptor binding. FEBS Open Bio. 2017;7:1557-1574 pubmed publisher |
Järnum S, Runström A, Bockermann R, Winstedt L, Crispin M, Kjellman C. Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy. Mol Cancer Ther. 2017;16:1887-1897 pubmed publisher |
Wessels U, Schick E, Ritter M, Kowalewsky F, Heinrich J, Stubenrauch K. Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation. Bioanalysis. 2017;9:849-859 pubmed publisher |
Zhang X, Olsen H, Chen S, So E, Zhou H, Burch E, et al. Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease. J Immunol. 2016;196:1165-76 pubmed publisher |
McEnaney P, Fitzgerald K, Zhang A, Douglass E, Shan W, Balog A, et al. Chemically synthesized molecules with the targeting and effector functions of antibodies. J Am Chem Soc. 2014;136:18034-43 pubmed publisher |
Yang Z, Ramsey J, Hamza T, Zhang Y, Li S, Yfantis H, et al. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab. Infect Immun. 2015;83:822-31 pubmed publisher |
Meuris L, Santens F, Elson G, Festjens N, Boone M, Dos Santos A, et al. GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nat Biotechnol. 2014;32:485-9 pubmed publisher |
Xie J, Yamniuk A, Borowski V, Kuhn R, Susulic V, Rex Rabe S, et al. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases. J Immunol. 2014;192:4083-92 pubmed publisher |
Derer S, Glorius P, Schlaeth M, Lohse S, Klausz K, Muchhal U, et al. Increasing Fc?RIIa affinity of an Fc?RIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity. MAbs. 2014;6:409-21 pubmed publisher |
Berntzen G, Andersen J, Ustgård K, Michaelsen T, Mousavi S, Qian J, et al. Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation. J Biol Chem. 2009;284:1126-35 pubmed publisher |
Richards J, Karki S, Lazar G, Chen H, Dang W, Desjarlais J. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol Cancer Ther. 2008;7:2517-27 pubmed publisher |
